Align Technology (ALGN) Stock: Buy, Sell, or Hold?
ALGN - Align Technology Inc
$145.35
0.00 (0.00%)
▼
5d:
-0.19%
30d:
-6.2%
90d:
-21.23%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When ALGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALGN shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$251.65
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$156.25
7.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALGN is currently trading at $145.34, which is considered oversold relative to its 30-day fair value range of $146.76 to $157.75. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.6) compared to its historical average (14.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ALGN is in a downtrend. The price is currently testing key support at $142.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $206.36 (+42.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALGN is in a downtrend. The price is currently testing key support at $142.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $206.36 (+42.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$146.76 -
$157.75
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding ALGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.0% below Wall St target ($206.36)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$146.76 -
$157.75
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$142.24
Resistance Level
$154.10
Current Trend
Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.62
Wall Street Target
$206.36
(+42.0%)
Revenue Growth (YoY)
4.3%
Earnings Growth (YoY)
-12.1%
Profit Margin
10.0%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
11.6 vs 14.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$136.48
(-6%)
2-Year Target
$128.15
(-12%)
3-Year Target
$120.34
(-17%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$145.99
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 10.8%)
$346.71
(+139%)
Base:
(SPY PE: 11.6, Growth: 10.8%)
$197.54
(+36%)
Bear:
(PE: 9.9, Growth: 10.8%)
$167.91
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 25.23 | Current EPS (TTM): $5.76
Bull Case
$319.77
(+120%)
Analyst growth 100.0%, PE expands to 27.8
Base Case
$290.70
(+100%)
Market implied 100.0%, PE stable at 25.2
Bear Case
$98.84
(-32%)
Severe decline -20.0%, PE contracts to 21.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.6 to 14.1
Stabilization Target:
$176.32
(+21.3%)
PE Expansion Potential:
+21.3%
Share & Embed Analysis
Last updated: October 02, 2026 3:45 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
Data refreshes hourly during market hours. Next update: 4:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
Advanced ALGN Option Strategies
Professional options setups generated by AI based on today's ALGN price and gamma walls.